April 2018

Providence Cancer Institute is currently conducting more than 130 research studies, including clinical trials of targeted therapies and novel immunotherapy approaches. Please see the links below for studies in specific disease areas.

Immunotherapy studies for advanced melanoma

Providence Cancer Institute, an international leader in melanoma research and treatment, currently has more than 10 studies of investiga-tional and FDA-approved immunotherapies open for people with advanced melanoma, including two new studies: A Phase 1 dose-escalating trial of AEB1102 A Phase 3 study comparing the effective-ness of BMS-986205 and nivolumab to nivolumab alone Read More About These Studies

All current open studies:

Brain Cancer Breast Cancer Gastrointestinal Cancers  Genitourinary Cancers Gynecologic Cancers

Hematologic Cancers Lung Cancer Melanoma Oral, Head and Neck Cancers Phase 1 Trials

Find additional studies for many types of cancer in Multiple Tumor Types.

New studies are posted frequently - please check our  website  for a complete list of our current studies. For more information, call 503-215-2614.

Refer A Patient

Email Our Team

See All Open Studies

Immunotherapy Research

Sign up to receive this newsletter

‌ ‌ ‌